胃がん診断施術の世界市場レポート 2024

胃がん診断施術の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には7.1%の年間複合成長率（CAGR）で18億8,000万米ドルに成長すると予想されます。予測期間で予想される成長は、ポイントオブケア検査の増加、新規バイオマーカーのイントロダクション、個別化医療への移行、次世代シーケンシングの採用、内視鏡画像診断法の強化によるものと考えられます。予測期間中に予想される主な動向には、ナノテクノロジーの統合、ビッグデータ分析の導入、微生物叢分析の応用、患者中心のアプローチの増加、診断における遠隔医療の役割などが含まれます。

胃腸疾患の有病率の増加は、胃がん診断施術市場で予想される成長の原動力となっています。胃腸障害には、消化器系のさまざまな部分や肝臓や膵臓などの補助臓器に影響を及ぼすさまざまな病気が含まれます。 胃がん診断施術は、内視鏡検査や生検などの方法で胃がんに対処するために不可欠です。したがって、胃腸疾患の発生率の拡大が市場の成長に貢献しています。たとえば、消化器科サービスを専門とする米国の医療施設であるGI Associates &Endoscopy Centerが実施した研究では、33か国の73,076人が参加し、2022年 8月には被験者の40%が機能性胃腸疾患を患っていたことが明らかになりました。胃腸疾患の有病率の増加は、胃がん診断施術市場の成長を推進する重要な要因です。

喫煙率の上昇は、将来胃がん診断施術市場の成長を促進すると予想されます。喫煙には、タバコやその他の物質を燃やすことによって発生する煙の吸入と吐き出しが含まれます。 胃がん診断施術は、早期発見を可能にし、前がん病変を特定し、個別の治療計画を策定し、コミュニケーションと調整を促進し、胃粘膜と胃粘膜の包括的な評価を提供することにより、喫煙歴のある人や喫煙関連がんのリスクがある人にとって重要な役割を果たします。周囲の組織。スイスに拠点を置く政府間機関である世界保健機関の2023年7月の報告書によると、毎年800万人以上がタバコによって死亡しており、その中には副流煙を吸う非喫煙者130万人が含まれています。したがって、喫煙率の上昇は、胃がん診断施術市場の成長の主要な推進力です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の胃がん診断処置市場、処置タイプ別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 内視鏡手術
• 生検
• 組織検査
• 臨床検査
• 体外診断検査
• 画像検査
• 分子診断学
• 多重化分子診断
• 免疫学的検査
• その他の手続きタイプ
• 世界の胃がん診断市場、症状タイプ別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 症状あり
• 無症状
• 世界の胃がん診断市場、提供タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 機器
• 試薬および消耗品
• サービス
• 世界の胃がん診断市場、体液タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 血液
• 尿
• 唾液
• 胃液
• 組織
• その他の体液
• 世界の胃がん診断市場、疾患適応別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 早期胃がん
• 進行胃がん

第7章 地域および国の分析

• 世界の胃がん診断市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の胃がん診断市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 胃がん診断市場の競合情勢
• 胃がん診断市場の企業プロファイル
  • Pfizer Inc.
  • Johnson &Johnson Co
  • F. Hoffmann La Roche Ltd.
  • Merck &Co. Inc.
  • Bayer AG

第31章 その他の大手および革新的な企業

• Novartis AG
• Bristol-Myers Squibb Company
• Thermo Fisher Scientific Inc.
• AstraZeneca plc
• Abbott Laboratories Inc.
• Sanofi SA
• Eli Lilly and Company
• Otsuka Pharmaceutical Co Ltd.
• AdventHealth
• Atrium Health
• Astellas Pharma Inc
• Bausch Health Companies Inc.
• Agilent Technologies Inc.
• Ipsen Pharma
• Hartford HealthCare

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

The diagnostic procedure for gastric cancer involves the identification and treatment of cancerous cells in the stomach. This procedure is crucial for diagnosing stomach cancer.

Key procedures in the diagnostic process for gastric cancer include endoscopic procedures, biopsies, tissue tests, laboratory tests, in-vitro diagnostic tests, imaging tests, molecular diagnostics, multiplexing molecular diagnostics, immunoassays, and others. The endoscopic procedure involves the examination of internal organs, such as the gastrointestinal tract, by inserting a long, thin tube directly into the body. This endoscopy procedure is utilized in gastric cancer diagnosis, addressing both symptomatic and asymptomatic cases, and encompasses instruments, reagents and consumables, and services. Various body fluids, including blood, urine, saliva, stomach juice, and tissue, are required for the procedure. These fluids aid in the detection and treatment of both early and advanced gastric cancer.

The gastric cancer diagnostic procedure market research report is one of a series of new reports from The Business Research Company that provides gastric cancer diagnostic procedure market statistics, including the gastric cancer diagnostic procedure industry's global market size, regional shares, competitors with a gastric cancer diagnostic procedure market share, detailed gastric cancer diagnostic procedure market segments, market trends, and opportunities, and any further data you may need to thrive in the gastric cancer diagnostic procedure industry. This gastric cancer diagnostic procedure market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The gastric cancer diagnostic procedure market size has grown strongly in recent years. It will grow from $1.32 billion in 2023 to $1.43 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth witnessed in the historical period can be ascribed to advancements in biopsy techniques, augmented research funding, the evolution of biomarker discovery, enhanced pathological analysis, and changes in screening guidelines.

The gastric cancer diagnostic procedure market size is expected to see strong growth in the next few years. It will grow to $1.88 billion in 2028 at a compound annual growth rate (CAGR) of 7.1%. The anticipated growth in the forecast period can be attributed to an increase in point-of-care testing, the introduction of novel biomarkers, a shift towards personalized medicine, the adoption of next-generation sequencing, and enhanced endoscopic imaging modalities. Major trends expected in the forecast period include the integration of nanotechnology, the adoption of big data analytics, the application of microbiota analysis, increased patient-centric approaches, and the role of telehealth in diagnostics.

The increasing prevalence of gastrointestinal diseases is a driving force behind the anticipated growth in the gastric cancer diagnostic procedure market. Gastrointestinal disorders encompass a range of illnesses affecting various sections of the digestive system and supporting organs, including the liver and pancreas. The gastric cancer diagnostic procedure is essential for addressing stomach cancer through methods such as endoscopy and biopsy. Therefore, the expanding incidence of gastrointestinal diseases is contributing to the market's growth. For instance, a study conducted by GI Associates & Endoscopy Center, a US-based medical facility specializing in gastroenterology services, involved 73,076 people from 33 nations, revealing that 40% of the subjects suffered from a functional gastrointestinal illness in August 2022. Hence, the increasing prevalence of gastrointestinal diseases is a significant factor propelling the growth of the gastric cancer diagnostic procedure market.

The rising prevalence of smoking is expected to drive the growth of the gastric cancer diagnostic procedure market in the future. Smoking involves the inhalation and exhalation of smoke produced by burning tobacco or other substances. Gastric cancer diagnostic procedures play a crucial role for individuals with a history of smoking or those at risk of smoking-related cancers by enabling early detection, identifying precancerous lesions, developing personalized treatment plans, facilitating communication and coordination, and providing a comprehensive assessment of the gastric mucosa and surrounding tissues. According to a report by The World Health Organization, a Switzerland-based intergovernmental organization, in July 2023, more than 8 million people are killed by tobacco each year, including 1.3 million non-smokers who inhale second-hand smoke. Therefore, the rising prevalence of smoking is a key driver of the growth of the gastric cancer diagnostic procedure market.

Technological advancements represent a prominent trend gaining momentum in the gastric cancer diagnostic market. Leading companies in the gastric cancer diagnostic market are actively incorporating new technologies to maintain their competitive positions. For example, in June 2022, Ibex Medical Analytics, an Israel-based provider of AI-powered diagnostics for health organizations, introduced Galen Gastric, the world's first AI-powered solution designed for gastric cancer detection. Galen Gastric serves as an integrated diagnostic tool assisting pathologists in identifying stomach cancer, H. pylori, and other critical clinical findings, contributing to faster turnaround times and improved diagnostic workflows.

Prominent companies in the gastric cancer diagnostic procedure market are strategically focusing on innovative products such as tissue staining platforms to drive revenue growth. The tissue staining platform aims to deliver rapid and precise test results, enabling medical professionals to make timely decisions regarding patient care. In June 2022, F. Hoffmann-La Roche AG, a Switzerland-based healthcare company, introduced the benchmark ultra plus system. This system, building on the proven technology of the benchmark ultra system, provides a fully automated workflow for immunohistochemistry (IHC) and in-situ hybridization (ISH) slide staining. It enhances the laboratory experience with features such as a retractable work surface, improved sliding drawers, indicator lights, and remote monitoring via a connected device, addressing user feedback. The system emphasizes efficient workflow, testing efficiency, and eco-friendly attributes.

In April 2021, Amgen, a US-based biopharmaceutical company, completed the acquisition of Five Prime Therapeutics for $1.9 billion. This strategic move enables Amgen to introduce innovative, best-in-class diagnostic products to the market, contributing to the growth of the company's presence in gastric cancer diagnostics and supporting its international expansion strategy. Five Prime Therapeutics, a US-based clinical-stage biotechnology company, specializes in providing gastric cancer diagnostic services.

Major companies operating in the gastric cancer diagnostic procedure market report are Pfizer Inc., Johnson & Johnson Co, F. Hoffmann La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca PLC, Abbott Laboratories Inc., Sanofi SA, Eli Lilly and Company, Otsuka Pharmaceutical Co Ltd., AdventHealth, Atrium Health, Astellas Pharma Inc., Bausch Health Companies Inc., Agilent Technologies Inc., Ipsen Pharma, Hartford HealthCare, Myriad Genetics Inc., Myriad Genetics Inc., NovoCure Limited, Foundation Medicine Inc., Biocept Inc.

North America was the largest region in the gastric cancer diagnostics procedure market in 2023. The regions covered in the gastric cancer diagnostic procedure market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the gastric cancer diagnostic procedure market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gastric cancer diagnostics procedure market includes revenues earned by entities that provide diagnostic procedures such as surgery, chemotherapy, and radiation therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gastric Cancer Diagnostic Procedure Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gastric cancer diagnostic procedure market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gastric cancer diagnostic procedure ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gastric cancer diagnostic procedure market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Procedure Type: Endoscopic Procedure; Biopsy; Tissue tests; Lab tests; In-vitro Diagnostic Tests; Imaging Tests; Molecular Diagnostics; Multiplexing Molecular Diagnostics; Immunoassays; Other Procedure Types
• 2) By Symptom Type: Symptomatic; Asymptomatic
• 3) By Offering Type: Instruments; Reagents and Consumables; Services
• 4) By Body Fluid Type: Blood; Urine; Saliva; Stomach Juice; Tissue; Other Body Fluid
• 5) By Disease Indication: Early Gastric Cancer; Advanced Gastric Cancer
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Co; F. Hoffmann La Roche Ltd.; Merck & Co. Inc.; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Gastric Cancer Diagnostic Procedure Market Characteristics

3. Gastric Cancer Diagnostic Procedure Market Trends And Strategies

4. Gastric Cancer Diagnostic Procedure Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Gastric Cancer Diagnostic Procedure Market Size and Growth

• 5.1. Global Gastric Cancer Diagnostic Procedure Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Gastric Cancer Diagnostic Procedure Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Gastric Cancer Diagnostic Procedure Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Gastric Cancer Diagnostic Procedure Market Segmentation

• 6.1. Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Endoscopic Procedure
• Biopsy
• Tissue tests
• Lab tests
• In-vitro Diagnostic Tests
• Imaging Tests
• Molecular Diagnostics
• Multiplexing Molecular Diagnostics
• Immunoassays
• Other Procedure Types
• 6.2. Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Symptomatic
• Asymptomatic
• 6.3. Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Instruments
• Reagents and Consumables
• Services
• 6.4. Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Body Fluid Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Blood
• Urine
• Saliva
• Stomach Juice
• Tissue
• Other Body Fluid
• 6.5. Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Early Gastric Cancer
• Advanced Gastric Cancer

7. Gastric Cancer Diagnostic Procedure Market Regional And Country Analysis

• 7.1. Global Gastric Cancer Diagnostic Procedure Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Gastric Cancer Diagnostic Procedure Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Gastric Cancer Diagnostic Procedure Market

• 8.1. Asia-Pacific Gastric Cancer Diagnostic Procedure Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Gastric Cancer Diagnostic Procedure Market

• 9.1. China Gastric Cancer Diagnostic Procedure Market Overview
• 9.2. China Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Gastric Cancer Diagnostic Procedure Market

• 10.1. India Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Gastric Cancer Diagnostic Procedure Market

• 11.1. Japan Gastric Cancer Diagnostic Procedure Market Overview
• 11.2. Japan Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Gastric Cancer Diagnostic Procedure Market

• 12.1. Australia Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Gastric Cancer Diagnostic Procedure Market

• 13.1. Indonesia Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Gastric Cancer Diagnostic Procedure Market

• 14.1. South Korea Gastric Cancer Diagnostic Procedure Market Overview
• 14.2. South Korea Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Gastric Cancer Diagnostic Procedure Market

• 15.1. Western Europe Gastric Cancer Diagnostic Procedure Market Overview
• 15.2. Western Europe Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Gastric Cancer Diagnostic Procedure Market

• 16.1. UK Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Gastric Cancer Diagnostic Procedure Market

• 17.1. Germany Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Gastric Cancer Diagnostic Procedure Market

• 18.1. France Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Gastric Cancer Diagnostic Procedure Market

• 19.1. Italy Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Gastric Cancer Diagnostic Procedure Market

• 20.1. Spain Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Gastric Cancer Diagnostic Procedure Market

• 21.1. Eastern Europe Gastric Cancer Diagnostic Procedure Market Overview
• 21.2. Eastern Europe Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Gastric Cancer Diagnostic Procedure Market

• 22.1. Russia Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Gastric Cancer Diagnostic Procedure Market

• 23.1. North America Gastric Cancer Diagnostic Procedure Market Overview
• 23.2. North America Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Gastric Cancer Diagnostic Procedure Market

• 24.1. USA Gastric Cancer Diagnostic Procedure Market Overview
• 24.2. USA Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Gastric Cancer Diagnostic Procedure Market

• 25.1. Canada Gastric Cancer Diagnostic Procedure Market Overview
• 25.2. Canada Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Gastric Cancer Diagnostic Procedure Market

• 26.1. South America Gastric Cancer Diagnostic Procedure Market Overview
• 26.2. South America Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Gastric Cancer Diagnostic Procedure Market

• 27.1. Brazil Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Gastric Cancer Diagnostic Procedure Market

• 28.1. Middle East Gastric Cancer Diagnostic Procedure Market Overview
• 28.2. Middle East Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Gastric Cancer Diagnostic Procedure Market

• 29.1. Africa Gastric Cancer Diagnostic Procedure Market Overview
• 29.2. Africa Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Gastric Cancer Diagnostic Procedure Market Competitive Landscape And Company Profiles

• 30.1. Gastric Cancer Diagnostic Procedure Market Competitive Landscape
• 30.2. Gastric Cancer Diagnostic Procedure Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Johnson & Johnson Co
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. F. Hoffmann La Roche Ltd.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Merck & Co. Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Bayer AG
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Gastric Cancer Diagnostic Procedure Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Bristol-Myers Squibb Company
• 31.3. Thermo Fisher Scientific Inc.
• 31.4. AstraZeneca plc
• 31.5. Abbott Laboratories Inc.
• 31.6. Sanofi SA
• 31.7. Eli Lilly and Company
• 31.8. Otsuka Pharmaceutical Co Ltd.
• 31.9. AdventHealth
• 31.10. Atrium Health
• 31.11. Astellas Pharma Inc
• 31.12. Bausch Health Companies Inc.
• 31.13. Agilent Technologies Inc.
• 31.14. Ipsen Pharma
• 31.15. Hartford HealthCare

32. Global Gastric Cancer Diagnostic Procedure Market Competitive Benchmarking

33. Global Gastric Cancer Diagnostic Procedure Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Gastric Cancer Diagnostic Procedure Market

35. Gastric Cancer Diagnostic Procedure Market Future Outlook and Potential Analysis

• 35.1 Gastric Cancer Diagnostic Procedure Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Gastric Cancer Diagnostic Procedure Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Gastric Cancer Diagnostic Procedure Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer